Trade Summary

1 week ago, Wierenga Wendell, serving as Dir at Cytokinetics Inc (CYTK), sold 20,000 shares at $66.14 per share, for a total transaction value of $1,322,800.00. Following this transaction, Wierenga Wendell now holds 32,444 shares of CYTK.

This sale represents a 38.00% decrease in Wierenga Wendell's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 1 day after the trade was made.

Cytokinetics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.